Webinars
Page Access:

Sort List of Events By:
Progress and Challenges in Antiphospholipid Antibody Testing
Tuesday
November 11, 2014




Progress and Challenges in Antiphospholipid Antibody Testing is part of the 2014 Clinical Chemistry Series of webinars. Because of the unique challenges of antiphospholipid testing and results interpretation of results, clinical labs...

1.0 Credits

Using CPOE, Test Formulary and Algorithm to Control Utilization
Monday
November 17, 2014




Reducing inappropriate or unnecessary testing is a common cost-cutting initiative for labs today. Join AACC for this 60-minute webinar and hear how Leo Serrano and his team at Broward Health System cut costs by more than $800,000 in FY2013 using...

1.0 Credits

Clinical Applications of Recently Approved Biomarkers of Acute Kidney Injury
Wednesday
November 19, 2014




The recent FDA approval of a new biomarker for acute kidney injury (AKI) gives clinicians one more tool to help identify patients at risk of developing AKI, a condition that is now recognized as a major risk factor for chronic kidney disease...

1.0 Credits

Using LC/MS-MS versus Immunoassay for Thyroid Testing
Thursday
November 20, 2014




Now that more labs are using LC/MS-MS to perform a variety of laboratory analyses, researchers are discovering that this new technology is providing a new perspective on some analytes that have traditionally been measured using immunoassays. For...

1.00 Credits

Trends in Flow Cytometry
Tuesday
December 02, 2014




Trends in Flow Cytometry is part of the 2014 Seattle Children’s Hospital Series of webinars. Flow cytometry is part of a rapidly developing new generation of high-precision testing methods.  Attend this webinar to learn the state-of-the-art...

1.00 Credits

Current Issues in Laboratory Testing for Rheumatoid Arthritis
Tuesday
December 09, 2014




Current Issues in Laboratory Testing for Rheumatoid Arthritis is part of the 2014 Clinical Chemistry Series of webinars. What do third-generation anti-CCP, anti-CARP and anti-biological therapeutic immunoassays have to offer...

1.0 Credits